The firm is currently scrutinizing several high-profile agreements, including the acquisition of Apogee Therapeutics (NASDAQ: APGE) by AbbVie for $135.11 per share in cash. Investigators are also reviewing the sale of Identiv, Inc.’s (NASDAQ: INVE) IoT business and Thai subsidiary to Trackonomy Systems, alongside the merger between Colony Bankcorp (NYSE: CBAN) and First Reliance Bancshares (OTCQX: FSRL).
In section Releases
Halper Sadeh Launches Investigations into Four Corporate Deals
Investors are questioning whether the proposed sales and mergers involving Apogee Therapeutics, Identiv, Colony Bankcorp, and First Reliance Bancshares prioritize leadership over shareholder value. New York-based law firm Halper Sadeh LLC has initiated formal reviews into these transactions, citing potential breaches of fiduciary duties and federal securities law violations.
Attorneys at Halper Sadeh contend that these deals may contain restrictive terms that discourage superior competing offers. The firm is evaluating whether shareholders are receiving adequate compensation and sufficient transparency regarding the long-term impact of these transitions. Affected investors are being encouraged to review their rights, with the firm operating on a contingent fee basis to pursue potential increased consideration or additional corporate disclosures.
Comments (0)
No comments yet. Be the first!